Self-testing and self-management of oral anticoagulation therapy in children

Thrombosis and Haemostasis

Volumn 106, Issue 3, 2011, Pages 391-397

  Christensen, Thomas Decker ^a   Larsen, Torben Bjerregaard ^b   Hjortdal, Vibeke E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anticoagulation; Paediatric; Point of care; Self management; Self testing

Indexed keywords

ANTICOAGULANT AGENT;

ACCURACY; ANTICOAGULANT THERAPY; BLEEDING; CAVOPULMONARY CONNECTION; DRUG FATALITY; DRUG INDICATION; EDUCATION PROGRAM; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SELF CARE; SELF EVALUATION; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

ADOLESCENT; ANTICOAGULANTS; CHILD; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; INTERNATIONAL NORMALIZED RATIO; PATIENT COMPLIANCE; QUALITY OF LIFE; SELF ADMINISTRATION; SELF CARE; THROMBOEMBOLISM;

EID: 80052309725     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-04-0217     Document Type: Review

References (43)

1. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S-198S.
2. Andrew M. Indications and drugs for anticoagulation therapy in children. Thromb Res 1996; 81: S61-S73.
3. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-352
4. Mähönen S, Riikonen P, Vaatainen RL, et al. Oral anticoagulant treatment in children based on monitoring at home. Acta Paediatr 2004; 93: 687-691
5. Bauman ME, Conroy S, Massicotte MP. Point-of-care INR measurements in children requiring warfarin: what has been evaluated and future directions. Pediatric Health 2008; 2: 651-659
6. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-639
7. Lindh JD, Holm L, Dahl ML, et al. Incidence and predictors of severe bleeding during warfarin treatment. J Thromb Thrombolysis 2008; 25: 151-159
8. Sönksen PH, Judd SL, Lowy C. Home monitoring of blood-glucose. Method for improving diabetic control. Lancet 1978; 1: 729-732
9. Thompson JL, Sundt TM, Sarano ME, et al. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Ann Thorac Surg 2008; 85: 2046-2050
10. Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al. Self-monitoring and selfmanagement of oral anticoagulation. Cochrane Database Syst Rev 2010; 4: CD003839.
11. Andrew M, Marzinotto V, Brooker LA, et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71: 265-269
12. Van LY, Rosendaal FR, Cannegieter SC. Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants. J Thromb Haemost 2008; 6: 451-456
13. Bauman ME, Black K, Bauman ML, et al. EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease. Thromb Res 2010; 126: e110-e115.
14. Jones S, Newall F, Manias E, et al. Assessing outcome measures of oral anticoagulation management in children. Thromb Res 2011; 127: 75-80
15. Bruce AA, Bauman ME, Black K, et al. Development and preliminary evaluation of the KIDCLOT PAC QL: a new health-related quality of life measure for pediatric long-term anticoagulation therapy. Thromb Res 2010; 126: e116-e121.
16. Massicotte P, Marzinotto V, Vegh P, et al. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 1995; 127: 389-394
17. Christensen TD, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. Selfmanagement of oral anticoagulation in children with congenital heart disease. Cardiol Young 2001; 11: 269-276
18. Günther T, Mazzitelli D, Schreiber C, et al. Mitral-valve replacement in children under 6 years of age. Eur J Cardiothorac Surg 2000; 17: 426-430
19. Nowatzke WL, Landt M, Smith C, et al. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatr Hematol Oncol 2003; 25: 33-37
20. Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593
21. Reiss N, Blanz U, Breymann T, et al. Mechanical valve replacement of the systemic atrioventricular valve in children. ASAIO J 2006; 52: 559-561
22. Christensen TD, Andersen NT, Maegaard M, et al. Oral anticoagulation therapy in children: successfully controlled by self-management. Heart Surg Forum 2004; 7: E321-E325.
23. Bauman ME, Black K, Kuhle S, et al. KIDCLOT: the importance of validated educational intervention for optimal long term warfarin management in children. Thromb Res 2009; 123: 707-709
24. Reiss N, Blanz U, Bairaktaris H, et al. Mechanical valve replacement in congenital heart defects in the era of international normalized ratio self-management. ASAIO J 2005; 51: 530-532
25. Newall F, Monagle P, Johnston L. Patient understanding of warfarin therapy: a review of education strategies. Hematology 2005; 10: 437-442
26. Paioni P, Kroiss S, Kagi E, et al. Self-monitoring of oral anticoagulation therapy in children. Acta Haematol 2009; 122: 58-63
27. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004; 18: 127-143
28. Braun S, Watzke H, Hasenkam JM, et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314
29. Williams VK, Griffiths AB. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting. Pathology 2007; 39: 575-579
30. Bauman ME, Black KL, Massicotte MP, et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103
31. Greenway A, Ignjatovic V, Summerhayes R, et al. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost 2009; 102: 159-165
32. Ignjatovic V, Barnes C, Newall F, et al. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost 2004; 92: 734-737
33. Newall F, Bauman M. Point-of-care antithrombotic monitoring in children. Thromb Res 2006; 118: 113-121
34. Van den Besselaar AM, Barrowcliffe TW, Houbouyan-Reveillard LL, et al. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2004; 2: 1946-1953
35. Christensen TD, Larsen TB, Jensen C, et al. International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy. Thromb Haemost 2009; 101: 563-569
36. Murray ET, Jennings I, Kitchen D, et al. Quality assurance for oral anticoagulation self management: a cluster randomized trial. J Thromb Haemost 2008; 6: 464-469
37. Poller L, Keown M, Ibrahim SA, et al. Quality assessment of CoaguChek pointof- care prothrombin time monitors: comparison of the European communityapproved procedure and conventional external quality assessment. Clin Chem 2006; 52: 1843-1847
38. Solvik UO, Stavelin A, Christensen NG, et al. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scand J Clin Lab Invest 2006; 66: 337-349
39. Jespersen J, Poller L, Van den Besselaar AM, et al. External quality assessment (EQA) for CoaguChek monitors. Thromb Haemost 2010; 103: 936-941
40. Poller L. Precision and accuracy of CoaguChek S and XS monitors: The need for external quality assessment. Thromb Haemost 2009; 101: 419-421
41. Salvador CH, Ruiz-Sanchez A, Gonzalez de Mingo MA, et al. Evaluation of a telemedicine- based service for the follow-up and monitoring of patients treated with oral anticoagulant therapy. IEEE Trans Inf Technol Biomed 2008; 12: 696-706
42. Oake N, van WC, Rodger MA, Forster AJ. Effect of an interactive voice response system on oral anticoagulant management. CMAJ 2009; 180: 927-933
43. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.